73 Results based on your selections.
Alumni & Friends

Brown’s faculty puts its expertise to work

Several faculty members across disciplines have shifted their research and community engagement efforts to focus specifically on COVID-19. Through their expertise and collaboration, they're providing a guide for addressing both the immediate and future effects of this global health and economic crisis.
Read Article
Alumni & Friends

Action Figure

Oncologist Wafik El-Deiry knows a lot about translating basic research into patient care. He just wants to do it faster.
Read Article
Alumni & Friends

Decoding Autism

Professor Eric Morrow and his team of researchers are using genetics to speed up the diagnosis and treatment of autism in children—and to provide hope to families.
Read Article
Alumni & Friends

Keeping computer science at the forefront

A newly established professorship honors the 50 year legacy of Professor Savage and launches an effort to further elevate one of Brown's premier programs.
Read Article
Professor Tricia Rose PhD ’93 talks about Brown’s action plan—from the ambitious vision to specific implementation goals—and helps “unpack the invisible practices that create the exclusions” in the first place.
Read Article
Alumni & Friends

Crucial conversations

From innovative research to seminars with prominent stakeholders and intellectuals, the Center for the Study of Race and Ethnicity in America broadens the dialogue on today’s pivotal issues.
Read Article
In a competitive academic landscape, endowed professorships supported by the BrownTogether campaign give Brown the means to attract and retain the best teachers and scholars, advancing the academic excellence and mission of the University.
Read Article
By bringing together Brown’s Warren Alpert Medical School and six medical practices employing more than 500 doctors, BPI will enable a new level of coordination for research, teaching and clinical care in southern New England.
Read Article
Brown’s new Biomedical Innovation Fund has made two grants to accelerate the commercialization of technologies — one for diagnosing drug dependence in newborns and a second for discovering anti-ALS medicines.
Read Article